» Articles » PMID: 29678511

Correlation of the New York Heart Association Classification and the Cardiopulmonary Exercise Test: A Systematic Review

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2018 Apr 22
PMID 29678511
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The New York Heart Association (NYHA) classification is frequently used in the management of heart failure but may be limited by patient and physician subjectivity. Cardiopulmonary exercise testing (CPET) provides a potentially more objective measurement of functional status. We aim to study the correlation between NYHA classification and peak oxygen consumption (pVO) on Cardiopulmonary Exercise Testing (CPET) within and across published studies.

Methods And Results: A systematic literature review on all studies reporting both NYHA class and CPET data was performed, and pVO from CPET was correlated to reported NYHA class within and across eligible studies. 38 studies involving 2645 patients were eligible. Heterogenity was assessed by the Q statistic, which is a χ2 test and marker of systematic differences between studies. Within each NYHA class, significant heterogeneity in pVO was seen across studies: NYHA I (n = 17, Q = 486.7, p < 0.0001), II (n = 24, Q = 381.0, p < 0.0001), III (n = 32, Q = 761.3, p < 0.0001) and IV (n = 5, Q = 12.8, p = 0.012). Significant differences in mean pVO were observed between NYHA I and II (23.8 vs 17.6 mL/(kg·min), p < 0.0001) and II and III (17.6 vs 13.3 mL/(kg·min), p < 0.0001); but not between NYHA III and IV (13.3 vs 12.5 mL/(kg·min), p = 0.45). These differences remained significant after adjusting for age, gender, ejection fraction and region of study.

Conclusion: There was a general inverse correlation between NYHA class and pVO However, significant heterogeneity in pVO exists across studies within each NYHA class. While the NYHA classification holds clinical value in heart failure management, direct comparison across studies may have its limitations.

Citing Articles

Cardiopulmonary exercise capacity markers and their link to symptom burden in patients at risk for heart failure with non-reduced ejection fraction.

Kwast S, Hoffmann J, Pokel C, Falz R, Schulze A, Schroter T Sci Rep. 2025; 15(1):8940.

PMID: 40089637 DOI: 10.1038/s41598-025-94172-1.


Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.

Sista A, Troxel A, Tarpey T, Parpia S, Goldhaber S, Stringer W Am Heart J. 2024; 281:112-122.

PMID: 39638275 PMC: 11810573. DOI: 10.1016/j.ahj.2024.11.016.


A scoping review on advancements in noninvasive wearable technology for heart failure management.

Scholte N, van Ravensberg A, Shakoor A, Boersma E, Ronner E, de Boer R NPJ Digit Med. 2024; 7(1):279.

PMID: 39396094 PMC: 11470936. DOI: 10.1038/s41746-024-01268-5.


Effect of lower-extremity muscle power training on muscle strength, balance function and walking ability in older adults with heart failure: a randomized controlled trial.

Sakaguchi M, Miyai N, Kobayashi H, Arita M Eur Geriatr Med. 2023; 15(2):361-370.

PMID: 38147270 DOI: 10.1007/s41999-023-00905-8.


Validity and Reliability of the Integrated Palliative Care Outcome Scale in Asian Heart Failure Patients.

Neo S, Tan J, Sim D, Ng E, Loh J, Yang G Palliat Med Rep. 2022; 3(1):287-295.

PMID: 36479550 PMC: 9712046. DOI: 10.1089/pmr.2022.0029.